書報討論
| 報告日期 | 報告題目 | 報告人 | |
|---|---|---|---|
| 2025-10-03 | Acute MeCP2 loss in adult mice reveals transcriptional and chromatin changes that precede neurological dysfunction and inform pathogenesis | 吳柏辰 | |
| 2025-10-03 | Lipid nanoparticle formulation for gene editing and RNA-based therapies for glioblastoma | 鄭恩慈 | |
| 2025-10-03 | Long Non-coding RNA Neat1, NOD-Like Receptor Family Protein 3 Inflammasome, and Acute Kidney Injury | 吳柏嶔 | |
| 2025-10-03 | Hypoxia-induced TGFBI maintains glioma stem cells by stabilizing EphA2 | 施姵辰 | |
| 2025-09-26 碩二進度報告 |
Therapeutic effects of dual suicide gene system in glioma and drug-resistant glioma cells | 陳塏倢 | |
| 2025-09-26 碩二進度報告 |
The Improvement of Polyunsaturated Fatty Acid Biosynthesis | 何宗颖 | |
| 2025-09-26 碩二進度報告 |
Development of Chitosan Nanocarriers to Enhance the Stability and Delivery of Antifungal Peptides | 周義盛 | |
| 2025-09-19 碩二進度報告 |
Effects of Octapeptide Repeat Copy Number on the Liquid–Liquid Phase Separation and Aggregation of the Prion Protein | 蔣嘉翰 | |
| 2025-09-19 碩二進度報告 |
AI-Assisted Discovery of a Repurposed FDA Drug Targeting KRAS G12D in Pancreatic Ductal Adenocarcinoma | 林思蓉 | |
| 2025-09-19 碩二進度報告 |
多形性膠質母細胞瘤對Temozolomide 之化療抗藥性主要源自於癌細胞中MGMT基因的高度表現 | 鄭恩慈 | |
| 2025-09-19 碩二進度報告 |
The role of TLR2 in modulating immune responses by H.para using Experimental Autoimmune Encephalomyelitis model | 許尚恩 | |
| 2025-09-19 碩二進度報告 |
Dual Targeting of CXCR7 Signaling and HDAC-Mediated Epigenetic Reprogramming to Disrupt the Desmoplasia in PDAC | 方淑怡 | |
| 2025-09-19 碩二進度報告 |
Exploring the role of TGFBI promotes focal adhesion of metastasis in pancreatic cancer | 施姵辰 |
